Foghorn Therapeutics (NASDAQ:FHTX) reported its Q4 earnings results on Thursday, March 7, 2024 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Foghorn Therapeutics beat estimated earnings by 25.0%, reporting an EPS of $-0.57 versus an estimate of $-0.76.

Revenue was up $1.58 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.41 which was followed by a 3.0% drop in the share price the next day.

Here's a look at Foghorn Therapeutics's past performance:

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Foghorn Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.